Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-400-1 | CAS number: 576-26-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Modified dose descriptor starting point:
- NOAEC
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- Justification:
- default value - subacute to chronic
- AF for other interspecies differences:
- 2.5
- Justification:
- default value - remaining differences
- AF for intraspecies differences:
- 5
- Justification:
- default value - workers
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor:
- NOAEC
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- Justification:
- default value - subacute to chronic
- AF for other interspecies differences:
- 2.5
- Justification:
- default value - remaining differences
- AF for intraspecies differences:
- 5
- Justification:
- default value - workers
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 16 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
- Overall assessment factor (AF):
- 12.5
- Dose descriptor starting point:
- NOAEC
- AF for dose response relationship:
- 1
- AF for other interspecies differences:
- 2.5
- Justification:
- default value - remaining differences
- AF for intraspecies differences:
- 5
- Justification:
- default value - workers
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- Justification:
- default value - subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- default value - rat
- AF for other interspecies differences:
- 2.5
- Justification:
- default value - remaining differences
- AF for intraspecies differences:
- 5
- Justification:
- default value - workers
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.6 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - workers
Based on the physico-chemical parameters, it could be concluded that absorption will be 100% for all routes of exposure (more details can be found in the part on toxicokinetics).
DNEL for long-term exposure - systemic effects – inhalation :
Batelle Columbus Division (BCD) (1991) performed a repeated dose toxicity study in male and female rats that were exposed to 2,6-xylenol (67, 200, 670 mg/m³) by whole body inhalation for 6 hours/day, 5 days/week, for a total of ten exposures, conducted within 14 days. The NOAEC for local and systemic effects was determined to be 200 mg/m³.
To compensate for the difference in exposure duration, the inhalation NOAEC is multiplied by a factor 6h/day/8h/day and is 150 mg/m³.
Following assessment factors were used:
-interspecies differences: 2.5 (no allometric scaling is required for inhalation)
-intraspecies differences: 5
-differences in duration: 6
-dose-response relationship: 1
With an overall assessment factor of 75, a DNEL of 150 mg/m³/75 = 2 mg/m³ is derived for the inhalation route – long-term systemic effects.
DNEL for acute exposure - systemic effects – inhalation :
The substance is classified for acute oral toxicity therefore, to protect from any possible adverse acute systemic effect, a DNEL for acute exposure inhalation has been set at 3x the long-term systemic DNEL.
DNEL for long-term exposure - local effects – inhalation:
Batelle Columbus Division (BCD) (1991) performed a repeated dose toxicity study in male and female rats that were treated with 2,6-xylenol (67, 200, 670 mg/m³) by whole body inhalation for 6 hours/day, 5 days/week, for a total of ten exposures, conducted within 14 days. The NOAEC for local effects was determined to be 200 mg/m³.
To compensate for the difference in exposure duration, the inhalation NOAEC is multiplied by a factor 6h/day/8h/day and is 150 mg/m³.
Following assessment factors were used:
-interspecies differences: 2.5
-intraspecies differences: 5
-differences in duration: 6
-dose-response relationship: 1
With an overall assessment factor of 75, a DNEL of 150 mg/m³/75 = 2 mg/m³ is derived for the inhalation route – local effects.
DNEL for acute exposure - local effects – inhalation :
Batelle Columbus Division (BCD) (1991) performed a repeated dose toxicity study in male and female rats that were treated with 2,6-xylenol (67, 200, 670 mg/m³) by whole body inhalation for 6 hours/day, 5 days/week, for a total of ten exposures, conducted within 14 days. Local effects appeared after 1 day of exposure: the NOAEC for local effects was determined to be 200 mg/m³.
Although the study is a repeated dose study, effects were observed after the first day of exposure. Therefore, 200 mg/m³ can be used as the starting dose for the acute DNEL derivation.
Following assessment factors were used:
-interspecies differences: 2.5
-intraspecies differences: 5
-differences in duration: 1
-dose-response relationship: 1
With an overall assessment factor of 12.5, an acute DNEL of 200 mg/m³/12.5 = 16 mg/m³ is derived for the inhalation route – local effects.
DNEL for long-term exposure - systemic effects – dermal :
No long-term data were available for the dermal route of exposure. Therefore, reliable data for the oral route were used.
RTI International Center for Life Sciences (2005) performed a combined repeated dose toxicity study with reproduction/developmental toxicity screening test using a structurally related analogous. F0 Sprague-Dawley Rats were dosed (via gavage) premating through the day prior to necropsy. Recovery males, females and 28 days females were dosed for 28 days. F1 animals were dosed post-weaning until the day before scheduled necropsy, at least 7 weeks duration. Animals received 0, 10, 100, or 200 mg/kg bw/day. A parental and F0 offspring NOEL of >= 200 mg/kg bw/day was observed. In addition to this study, a pre-natal developmental toxicity study was conducted with the registered substance where female rats received 0, 60, 180 or 540 mg/kg bw/day from gestation day 6 to 15. A lowest NOAEL for maternal toxicity (systemic toxicity) was obtained in this study because treatment at 180 mg/kg bw/day caused reductions in body weight gain and food consumption, and a statistically significant lower terminal weight when corrected for the uterus weight. Therefore, the starting dose for DNEL derivation is the NOAEL of 60 mg/kg bw/day for maternal toxicity, the lowest NOAEL obtained among the available studies.
Following assessment factors were used:
- interspecies differences: 2.5 x 4 = 10
- intraspecies differences: 5
- differences in duration: 6
- dose-response relationship: 1
With an overall assessment factor of 300, a DNEL for long-term exposure - systemic effects of 60 mg/kg bw/300 = 0.2 mg/kg bw/day is derived.
DNEL for acute exposure - systemic effects – dermal :
The substance is classified for acute dermal toxicity therefore, to protect from any possible adverse acute systemic effect, a DNEL for acute exposure dermal has been set at 3x the long-term systemic DNEL.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
For the general population, no DNEL was derived since 2,6-xylenol is only used in closed systems: no indirect exposure via the environment will occur. Moreover, no consumer use is considered.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.